Discontinued — last reported Q2 '25
International Flavors & Fragrances Pharma Solutions — Cost of Sales decreased by 62.2% to $68.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 63.6%, from $187.00M to $68.00M. Over 2 years (FY 2022 to FY 2024), Pharma Solutions — Cost of Sales shows relatively stable performance with a 1.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests margin compression, whereas a decrease relative to revenue suggests improved manufacturing efficiency or favorable input cost management.
Includes the direct costs attributable to the production and delivery of pharmaceutical ingredients, such as raw materia...
Standard metric across manufacturing industries, often referred to as Cost of Goods Sold (COGS).
iff_segment_pharma_solutions_cost_of_sales| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $175.25M | $175.25M | $175.25M | $175.25M | $188.00M | $188.00M | $188.00M | $188.00M | $181.00M | $187.00M | $178.00M | $173.00M | $180.00M | $68.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +7.3% | +0.0% | +0.0% | +0.0% | -3.7% | +3.3% | -4.8% | -2.8% | +4.0% | -62.2% |
| YoY Change | — | — | — | — | +7.3% | +7.3% | +7.3% | +7.3% | -3.7% | -0.5% | -5.3% | -8.0% | -0.6% | -63.6% |